Aerie Pharmaceuticals Inc Logo Image

Aerie Pharmaceuticals Inc

About Aerie Pharmaceuticals Inc

51-200 Employees
Based in Bedminster, New Jersey

Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases. Its product candidates include Rhopressa, which is a once-daily eye drop that reduces intraocular pressure (IOP) in patients with glaucoma or ocular hypertension and is in Phase III registration trials; and Roclatan, a once-daily eye drop to reduce IOP that has completed Phase IIb clinical trial in patients with open-angle glaucoma and ocular hypertension.

Ticker:
AERI
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Drug Manufacturers - Major (See More Drug Manufacturers - Major Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol